CADTH Canadian Drug Expert Committee recommendation: Sucroferric oxyhydroxide (Velphoro -- Vifor Fresenius Medical Care Renal Pharma Ltd.) indication : for the control of serum phosphorus levels in adult patients with end-stage renal disease (ESRD) on dialysis
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
CADTH
January 4, 2019, 2019
|
| Edition: | Final |
| Series: | CADTH common drug review
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Physical Description: | 1 PDF file (7 pages) |
|---|